Bereich
Dermatologie | Venerologie | Allergologie
DERMA · Dept. IV
S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 1: Classification and Diagnosis (ICD10 C82 - C86)
Dippel E, Meiß F, Mestel D, Nashan D, Nicolay J, Oschlies I, Schlaak M, Stoll C, Vag T, Weichenthal M, Wobser M, Loquai C, Lamos C, Klemke C, Assaf C, Becker J, von Bergwelt-Baildon M, Beyer M, Cozzio A, Eich H, Follmann M, Grabbe S, Hillen U, Klapper W, Stadler R. S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 1: Classification and Diagnosis (ICD10 C82 - C86). J Dtsch Dermatol Ges 2017; 15:1266-1273.
28.11.2017S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 1: Classification and Diagnosis (ICD10 C82 - C86)
28.11.2017J Dtsch Dermatol Ges 2017; 15:1266-1273
Dippel Edgar, Meiß Frank, Mestel Dominik, Nashan Dorothee, Nicolay Jan P, Oschlies Ilske, Schlaak Max, Stoll Christoph, Vag Tibor, Weichenthal Michael, Wobser Marion, Loquai Carmen, Lamos Cristina, Klemke Claus-Detlev, Assaf Chalid, Becker Jürgen C, von Bergwelt-Baildon Michael, Beyer Marc, Cozzio Antonio, Eich Hans Theodor, Follmann Markus, Grabbe Stephan, Hillen Uwe, Klapper Wolfram, Stadler Rudolf
Clinical assessment of skin phototypes: watch your words!
Trakatelli M, Del Marmol V, Stratigos A, Paoli J, Nagore E, Medenica L, De Vries E, Cozzio A, Correia O, Bylaite-Bucinskiene M, Bulliard J. Clinical assessment of skin phototypes: watch your words!. Eur J Dermatol 2017
24.11.2017Clinical assessment of skin phototypes: watch your words!
24.11.2017Eur J Dermatol 2017
Trakatelli Myrto, Del Marmol Véronique, Stratigos Alexander J, Paoli John, Nagore Eduardo, Medenica Ljiljana, De Vries Esther, Cozzio Antonio, Correia Osvaldo, Bylaite-Bucinskiene Matilda, Bulliard Jean-Luc
Component-resolved diagnosis and beyond: Multivariable regression models to predict severity of hazelnut allergy
Datema M, Le T, Lidholm J, Papadopoulos N, Popov T, Del Prado N, Purohit A, Reig I, Seneviratne S, Sinaniotis A, Versteeg S, Vieths S, Zwinderman A, Mills E, Fernandez-Rivas M, Kralimarkova T, Kowalski M, van Ree R, Asero R, Barreales L, Belohlavkova S, de Blay F, Clausen M, Dubakiene R, Fernández-Perez C, Fritsche P, Gislason D, Hoffmann-Sommergruber K, Jedrzejczak-Czechowicz M, Jongejan L, Knulst A, Ballmer-Weber B. Component-resolved diagnosis and beyond: Multivariable regression models to predict severity of hazelnut allergy. Allergy 2017; 73:549-559.
24.11.2017Component-resolved diagnosis and beyond: Multivariable regression models to predict severity of hazelnut allergy
24.11.2017Allergy 2017; 73:549-559
Datema M R, Le T-M, Lidholm J, Papadopoulos N G, Popov T A, Del Prado N, Purohit A, Reig I, Seneviratne S L, Sinaniotis A, Versteeg S A, Vieths S, Zwinderman A H, Mills E N C, Fernandez-Rivas M, Kralimarkova T Z, Kowalski M, van Ree R, Asero R, Barreales L, Belohlavkova S, de Blay F, Clausen M, Dubakiene R, Fernández-Perez C, Fritsche P, Gislason D, Hoffmann-Sommergruber K, Jedrzejczak-Czechowicz M, Jongejan L, Knulst A C, Ballmer-Weber Barbara
Clinical Disease Patterns in a Regional Swiss Cohort of 34 Pyoderma Gangrenosum Patients
Kolios A, French L, Navarini A, Kempf W, Anliker M, Kerl K, Guenova E, Hafner J, Nilsson J, Kündig T, Maul J, Meier B, Gübeli A, Cozzio A. Clinical Disease Patterns in a Regional Swiss Cohort of 34 Pyoderma Gangrenosum Patients. Dermatology (Basel) 2017
07.11.2017Clinical Disease Patterns in a Regional Swiss Cohort of 34 Pyoderma Gangrenosum Patients
07.11.2017Dermatology (Basel) 2017
Kolios Antonios G A, French Lars E, Navarini Alexander A, Kempf Werner, Anliker Mark, Kerl Katrin, Guenova Emmanuella, Hafner Jürg, Nilsson Jakob, Kündig Thomas, Maul Julia-Tatjana, Meier Barbara, Gübeli Alissa, Cozzio Antonio
Successful treatment of SAPHO syndrome with apremilast
Adamo S, Nilsson J, Krebs A, Steiner U, Cozzio A, French L, Kolios A. Successful treatment of SAPHO syndrome with apremilast. Br J Dermatol 2017
16.10.2017Successful treatment of SAPHO syndrome with apremilast
16.10.2017Br J Dermatol 2017
Adamo S, Nilsson J, Krebs A, Steiner U, Cozzio Antonio, French L E, Kolios A G A
Safety of shortened infusion times for combined ipilimumab and nivolumab
Gassenmaier M, Garbe C, Eigentler T, Doecker D, Mueller A, Kofler L, Wagner N, Scheu A, Lipp H, Forschner A. Safety of shortened infusion times for combined ipilimumab and nivolumab. Cancer Immunol Immunother 2017; 67:135-140.
07.10.2017Safety of shortened infusion times for combined ipilimumab and nivolumab
07.10.2017Cancer Immunol Immunother 2017; 67:135-140
Gassenmaier Maximilian, Garbe Claus, Eigentler Thomas Kurt, Doecker Dennis, Mueller Alisa, Kofler Lukas, Wagner Nikolaus, Scheu Alexander, Lipp Hans-Peter, Forschner Andrea
Tumor infiltrating lymphocytes in lymph node metastases of stage III melanoma correspond to response and survival in nine patients treated with ipilimumab at the time of stage IV disease
Diem S, Hasan Ali O, Ackermann C, Bomze D, Koelzer V, Jochum W, Speiser D, Mertz K, Flatz L. Tumor infiltrating lymphocytes in lymph node metastases of stage III melanoma correspond to response and survival in nine patients treated with ipilimumab at the time of stage IV disease. Cancer Immunol Immunother 2017; 67:39-45.
11.09.2017Tumor infiltrating lymphocytes in lymph node metastases of stage III melanoma correspond to response and survival in nine patients treated with ipilimumab at the time of stage IV disease
11.09.2017Cancer Immunol Immunother 2017; 67:39-45
Diem Stefan, Hasan Ali Omar, Ackermann Christoph J, Bomze David, Koelzer Viktor H, Jochum Wolfram, Speiser Daniel E, Mertz Kirsten D, Flatz Lukas
Swiss S1 guideline for the treatment of rosacea
Anzengruber F, Laffitte E, Brand C, Imhof L, Läuchli S, Goldblum D, Mainetti C, Cozzio A, Häusermann P, Yawalkar N, Feldmeyer L, Conrad C, Czernielewski J, Navarini A. Swiss S1 guideline for the treatment of rosacea. J Eur Acad Dermatol Venereol 2017; 31:1775-1791.
21.08.2017Swiss S1 guideline for the treatment of rosacea
21.08.2017J Eur Acad Dermatol Venereol 2017; 31:1775-1791
Anzengruber F, Laffitte E, Brand C, Imhof L, Läuchli S, Goldblum D, Mainetti C, Cozzio Antonio, Häusermann P, Yawalkar N, Feldmeyer L, Conrad C, Czernielewski J, Navarini A A
Comparison of pyoderma gangrenosum and hypertensive ischemic leg ulcer Martorell in a Swiss cohort
Kolios A, Hafner J, Luder C, Guenova E, Kerl K, Kempf W, Nilsson J, French L, Cozzio A. Comparison of pyoderma gangrenosum and hypertensive ischemic leg ulcer Martorell in a Swiss cohort. Br J Dermatol 2017
20.08.2017Comparison of pyoderma gangrenosum and hypertensive ischemic leg ulcer Martorell in a Swiss cohort
20.08.2017Br J Dermatol 2017
Kolios A G A, Hafner J, Luder C, Guenova E, Kerl K, Kempf W, Nilsson J, French L E, Cozzio Antonio
Interferon-γ-Driven iNOS: A Molecular Pathway to Terminal Shock in Arenavirus Hemorrhagic Fever
Remy M, Merkler D, Kaufmann B, Hanisch U, Bestmann L, Rieger T, Doras C, Fallet B, Kreutzfeldt M, Xu L, Regen T, Flatz L, Sahin M, Pinschewer D. Interferon-γ-Driven iNOS: A Molecular Pathway to Terminal Shock in Arenavirus Hemorrhagic Fever. Cell Host Microbe 2017; 22:354-365.e5.
17.08.2017Interferon-γ-Driven iNOS: A Molecular Pathway to Terminal Shock in Arenavirus Hemorrhagic Fever
17.08.2017Cell Host Microbe 2017; 22:354-365.e5
Remy Melissa M, Merkler Doron, Kaufmann Beat A, Hanisch Uwe-Karsten, Bestmann Lukas, Rieger Toni, Doras Camille, Fallet Benedict, Kreutzfeldt Mario, Xu Lifen, Regen Tommy, Flatz Lukas, Sahin Mehmet, Pinschewer Daniel D
European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
Krieg T, Quaglino P, Petit A, Parodi A, Panelius J, Orteu C, Olszewska M, Krasowska D, Kofoed K, Kárpáti S, Ranki A, Sanchez Schmidt J, Wutte N, Worm M, Wolf P, Tanew A, Taieb A, Sunderkötter C, Sticherling M, Skrok A, Seneschal J, Kähäri V, Just U, Rudnicka L, Denton C, Rongioletti F, Cutolo M, Mouthon L, Cozzio A, Kreuter A, Hunzelmann N, Moinzadeh P, Frasin L, Smith V, Jalili A, Frances C, Foeldvari I, Braae Olesen A, Bouaziz J, Bali G, Bagot M, Aberer E, Gabrielli A, Knobler R. European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes. J Eur Acad Dermatol Venereol 2017; 31:1401-1424.
09.08.2017European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
09.08.2017J Eur Acad Dermatol Venereol 2017; 31:1401-1424
Krieg T, Quaglino P, Petit A, Parodi A, Panelius J, Orteu C, Olszewska M, Krasowska D, Kofoed K, Kárpáti S, Ranki A, Sanchez Schmidt J M, Wutte N J, Worm M, Wolf P, Tanew A, Taieb A, Sunderkötter C, Sticherling M, Skrok A, Seneschal J, Kähäri V, Just U, Rudnicka L, Denton C P, Rongioletti F, Cutolo M, Mouthon L, Cozzio Antonio, Kreuter A, Hunzelmann N, Moinzadeh P, Frasin L A, Smith V, Jalili A, Frances C, Foeldvari I, Braae Olesen A, Bouaziz J, Bali G, Bagot M, Aberer E, Gabrielli A, Knobler R
European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis
Krieg T, Quaglino P, Petit A, Parodi A, Panelius J, Orteu C, Olszewska M, Krasowska D, Kofoed K, Kárpáti S, Ranki A, Sanchez Schmidt J, Wutte N, Worm M, Wolf P, Tanew A, Taieb A, Sunderkötter C, Sticherling M, Skrok A, Seneschal J, Kähäri V, Just U, Rudnicka L, Denton C, Rongioletti F, Cutolo M, Mouthon L, Cozzio A, Kreuter A, Hunzelmann N, Moinzadeh P, Frasin L, Smith V, Jalili A, Frances C, Foeldvari I, Braae Olesen A, Bouaziz J, Bali G, Bagot M, Aberer E, Gabrielli A, Knobler R. European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis. J Eur Acad Dermatol Venereol 2017; 31:1581-1594.
08.08.2017European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis
08.08.2017J Eur Acad Dermatol Venereol 2017; 31:1581-1594
Krieg T, Quaglino P, Petit A, Parodi A, Panelius J, Orteu C, Olszewska M, Krasowska D, Kofoed K, Kárpáti S, Ranki A, Sanchez Schmidt J M, Wutte N J, Worm M, Wolf P, Tanew A, Taieb A, Sunderkötter C, Sticherling M, Skrok A, Seneschal J, Kähäri V, Just U, Rudnicka L, Denton C P, Rongioletti F, Cutolo M, Mouthon L, Cozzio Antonio, Kreuter A, Hunzelmann N, Moinzadeh P, Frasin L A, Smith V, Jalili A, Frances C, Foeldvari I, Braae Olesen A, Bouaziz J, Bali G, Bagot M, Aberer E, Gabrielli A, Knobler R
Food challenges
Ballmer-Weber B, Beyer K. Food challenges. J Allergy Clin Immunol 2017; 141:69-71.e2.
27.07.2017Food challenges
27.07.2017J Allergy Clin Immunol 2017; 141:69-71.e2
Ballmer-Weber Barbara, Beyer Kirsten
Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab
Diem S, Schmid S, Krapf M, Flatz L, Born D, Jochum W, Templeton A, Früh M. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab. Lung Cancer 2017; 111:176-181.
24.07.2017Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab
24.07.2017Lung Cancer 2017; 111:176-181
Diem Stefan, Schmid Sabine, Krapf Mirjam, Flatz Lukas, Born Diana, Jochum Wolfram, Templeton Arnoud J, Früh Martin
Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study
Mangold A, Pittelkow M, Pujol R, Amitay-Laish I, Hodak E, Guenova E, Cozzio A, Saulite I, Davis M, Thompson A, Gniadecki R. Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study. J Am Acad Dermatol 2017; 77:719-727.
11.07.2017Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study
11.07.2017J Am Acad Dermatol 2017; 77:719-727
Mangold Aaron R, Pittelkow Mark R, Pujol Ramon M, Amitay-Laish Iris, Hodak Emmilia, Guenova Emmanuella, Cozzio Antonio, Saulite Ieva, Davis Mark D, Thompson Agnieszka K, Gniadecki Robert
Cutaneous Corynebacterium Infection Presenting with Disseminated Skin Nodules and Ulceration
Kolios A, Cozzio A, Zinkernagel A, French L, Kündig T. Cutaneous Corynebacterium Infection Presenting with Disseminated Skin Nodules and Ulceration. Case Rep Dermatol 2017; 9:8-12.
16.05.2017Cutaneous Corynebacterium Infection Presenting with Disseminated Skin Nodules and Ulceration
16.05.2017Case Rep Dermatol 2017; 9:8-12
Kolios Antonios G A, Cozzio Antonio, Zinkernagel Annelies S, French Lars E, Kündig Thomas M
Paradoxical ulcerative colitis during adalimumab treatment of psoriasis resolved by switch to ustekinumab
Kolios A, Biedermann L, Weber A, Navarini A, Meier J, Cozzio A, French L. Paradoxical ulcerative colitis during adalimumab treatment of psoriasis resolved by switch to ustekinumab. Br J Dermatol 2017
06.05.2017Paradoxical ulcerative colitis during adalimumab treatment of psoriasis resolved by switch to ustekinumab
06.05.2017Br J Dermatol 2017
Kolios A G A, Biedermann L, Weber A, Navarini A A, Meier J, Cozzio Antonio, French L E
Expression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advanced Tumor Stage in Patients with Esophageal Adenocarcinoma
Kollmann D, Guenova E, Preusser M, Asari R, Schatton T, Hötzenecker W, Cozzio A, Michal M, Kazakov D, Kristo I, Paireder M, Jomrich G, Chang Y, Jedamzik J, Desislava I, Schoppmann S. Expression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advanced Tumor Stage in Patients with Esophageal Adenocarcinoma. Ann Surg Oncol 2017; 24:2698-2706.
20.04.2017Expression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advanced Tumor Stage in Patients with Esophageal Adenocarcinoma
20.04.2017Ann Surg Oncol 2017; 24:2698-2706
Kollmann Dagmar, Guenova Emmanuella, Preusser Matthias, Asari Reza, Schatton Tobias, Hötzenecker Wolfram, Cozzio Antonio, Michal Michal, Kazakov Dmitry, Kristo Ivan, Paireder Matthias, Jomrich Gerd, Chang Yun-Tsan, Jedamzik Julia, Desislava Ignatova, Schoppmann Sebastian F
European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017
Trautinger F, Quaglino P, Ranki A, Scarisbrick J, Stadler R, Väkevä L, Vermeer M, Whittaker S, Willemze R, Pimpinelli N, Papadavid E, Eder J, Assaf C, Bagot M, Cozzio A, Dummer R, Gniadecki R, Klemke C, Ortiz-Romero P, Knobler R. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017. Eur J Cancer 2017; 77:57-74.
31.03.2017European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017
31.03.2017Eur J Cancer 2017; 77:57-74
Trautinger Franz, Quaglino Pietro, Ranki Annamari, Scarisbrick Julia, Stadler Rudolf, Väkevä Liisa, Vermeer Maarten H, Whittaker Sean, Willemze Rein, Pimpinelli Nicola, Papadavid Evangelia, Eder Johanna, Assaf Chalid, Bagot Martine, Cozzio Antonio, Dummer Reinhard, Gniadecki Robert, Klemke Claus-Detlev, Ortiz-Romero Pablo L, Knobler Robert
Spatiotemporally restricted arenavirus replication induces immune surveillance and type I interferon-dependent tumour regression
Kalkavan H, Rathbun J, Cannon P, Scheu S, Bauer J, Chauhan J, Häussinger D, Willimsky G, Löhning M, Schadendorf D, Brandau S, Schuler M, Lang P, Drexler I, von Laer D, Wollmann G, Sharma P, Kasper S, Helfrich I, Pandyra A, Gassa A, Virchow I, Flatz L, Brandenburg T, Namineni S, Heikenwalder M, Höchst B, Knolle P, Lang K. Spatiotemporally restricted arenavirus replication induces immune surveillance and type I interferon-dependent tumour regression. Nat Commun 2017; 8:14447.
01.03.2017Spatiotemporally restricted arenavirus replication induces immune surveillance and type I interferon-dependent tumour regression
01.03.2017Nat Commun 2017; 8:14447
Kalkavan Halime, Rathbun Jessica, Cannon Paula M, Scheu Stefanie, Bauer Jens, Chauhan Jagat, Häussinger Dieter, Willimsky Gerald, Löhning Max, Schadendorf Dirk, Brandau Sven, Schuler Martin, Lang Philipp A, Drexler Ingo, von Laer Dorothee, Wollmann Guido, Sharma Piyush, Kasper Stefan, Helfrich Iris, Pandyra Aleksandra A, Gassa Asmae, Virchow Isabel, Flatz Lukas, Brandenburg Tim, Namineni Sukumar, Heikenwalder Mathias, Höchst Bastian, Knolle Percy A, Lang Karl S